Search Within

David Chung

Formats
  1. Meeting Abstract (175)
  2. Journal Article (62)
  3. Research Letter (4)
  4. Correspondence (2)
  5. Book Section (1)
  6. Review (1)
Groups
  1. Bone Marrow Transplant (245)
  2. Center for Hematologic Malignancies (245)
  3. Department of Medicine (245)
  4. Hematologic Malignancies, Division of (245)
  5. Survivorship Research (218)
  6. Myeloma (187)

More Groups

People
  1. Sergio Giralt (205)
  2. Heather Landau (204)
  3. Alexander Lesokhin (172)
  4. Hani Hassoun (165)
  5. Gunjan Shah (153)
  6. Neha Korde (138)

More People

Years
  1. 2025 (2)
  2. 2024 (38)
  3. 2023 (40)
  4. 2022 (34)
  5. 2021 (15)
  6. 2020 (18)

More Years

Publications
  1. Blood (96)
  2. Clinical Lymphoma, Myeloma and Leukemia (44)
  3. Biology of Blood and Marrow Transplantation (28)
  4. Leukemia and Lymphoma (9)
  5. Journal of Clinical Oncology (8)
  6. Transplantation and Cellular Therapy (7)

More Publications

Publishers
  1. American Society of Hematology (101)
  2. Elsevier Inc. (82)
  3. Nature Publishing Group (12)
  4. American Association for Cancer Research (9)
  5. Taylor & Francis Group (9)
  6. American Society of Clinical Oncology (8)

More Publishers

Results (245)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker in multiple myeloma
    Journal Article

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C. R.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Rajeeve, S.; Costa, B. A.; Jurgens, E. M.; Nishimura, N.; Farzana, T.; Firestone, R. S.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Brown, S.; Devlin, S. M.; Costa, B. A.; Farzana, T.; Jurgens, E. M.; Firestone, R. S.; Nath, K.; Chung, D. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Initial results from the ASH research collaborative's COVID-19 outcomes in myeloma and the impact of vaccines (COSMIC): A decentralized, real-world evidence study for patients with multiple myeloma to monitor outcomes related to COVID-19 vaccines and infections
    Meeting Abstract

    Usmani, S. Z.; Semmel, E. A.; James, S.; Wood, W. A.; Schroeder, M. A.; Chung, D. J.; Rosenberg, A. S.; Zonder, J. A.; Rubinstein, S. M.; D'Souza, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Immune-MRD status informs tumor-MRD outcome prognostication in multiple myeloma patients on lenalidomide maintenance
    Meeting Abstract

    Firestone, R. S.; Simhal, A. K.; McAvoy, D.; Jurgens, E. M.; GarceĢs, J. J.; Nemirovsky, D.; Derkach, A.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A high-fiber dietary intervention (NUTRIVENTION) in precursor plasma cell disorders improves biomarkers of disease and may delay progression to myeloma
    Meeting Abstract

    Shah, U. A.; Cogrossi, L. L.; Derkach, A.; Castro, F.; Fei, T.; DeWolf, S.; Garces, J. J.; Policastro, A.; Grioni, M.; Sisti, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Development of the ASH Research Collaborative Multiple Myeloma Program: A multicenter, real-world evidence generation network
    Meeting Abstract

    Kumar, S.; Wood, W. A.; Anderson, K. C.; Semmel, E. A.; James, S.; Neuberg, D. S.; Hewitt, K.; Schroeder, M. A.; Chung, D. J.; Rosenberg, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Genomic complexity correlates with the degree of marrow independence of malignant plasma cells in the context of extramedullary disease
    Meeting Abstract

    Maclachlan, K. H.; Garces, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C. R.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Defining the rates of cytokine release syndrome associated with talquetamab step-up doses
    Meeting Abstract

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R. S.; Wang, A. X.; Korde, N.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; more...
    Blood (2024)

    Fulltext@MSK | Save